Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
eG Capital is a private equity firm focused on growth-stage investments in the healthcare, consumer, and education sectors, primarily across East Africa and Zambia. The firm distinguishes itself through a gender-lens investing strategy, prioritizing businesses that promote economic inclusion and provide essential services to women and families. In the healthcare sector, eG Capital targets investments in pharmaceutical manufacturing, medical distribution, and healthcare delivery platforms to enhance regional health infrastructure. A prominent example of their healthcare portfolio is Dawa Life Sciences, a leading pharmaceutical manufacturer in the region. The firm aims to drive significant social impact alongside competitive financial returns by strengthening regional supply chains and access to quality care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on eG Capital.